Overall, each of the alterations described, together with modifications in the composition and function of the microbial ecosystem, as well as variations in concentrations of different metabolites, elevated C-reactive protein and leptin, together with reduced adiponectin, promote a higher risk of metabolic comorbidities, particularly T2D, even in the absence of obesity [22]. This evidence concerns the gene LEP and type 2 diabetes mellitus.